Skip to main content

Table 1 Clinical data of MS patients and non-neurological controls

From: Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions

Case Age (years) Type of MS Sex Post-mortem
delay (h:min)
Disease duration (years) Lesion stages Tissue
1 51 SP m 11:00 >15 A P/F
2 56 SP m 8:00 27 CA P
3 49 RR-SP m 8:00 25 CA P
4 66 SP f 6:00 23 CA P/F
5 54 ND m 8:30 ND CA P
6 66 PP m 7:30 26 CA P
7 41 PP m 7:23 14 A P
8 54 ND m 8:30 15 A P
9 75 RR-SP m 7:45 24 CIA P
10 70 SP f 6:55 40 CIA P
11 44 PP m 12:00 16 CA, A P
12 50 RR-SP f 7:35 17 CA P
13 61 SP m 9:15 14 CA P
14 64 RR-SP f 10:10 38 CIA P
15 70 RR-SP m 7:45 46 CIA F
16 77 PP m 4:15 26 A F
17 48 SP f 11:40 23 CIA F
18 56 SP m 10:10 13 CA F
19 84 control f 6:55 NA NA P
20 56 control m 9:15 NA NA P
21 62 control m 7:20 NA NA P
22 82 control m 6:20 NA NA P
23 55 control m 7:30 NA NA F
24 76 control m 6:45 NA NA F
25 70 control f 6:15 NA NA F
  1. SP secondary progressive MS, PP primary progressive MS, ND not determined, NA not applicable, m male, f female, A active lesion, CA chronic active lesion, CIA chronic inactive lesion, P paraffinembedded tissue, F frozen tissue